 |
|
 |
 |

Home > Company Index > Drugs > Drug Manufacturers - Other > Eisai Company, Ltd.
 |
Eisai Company, Ltd. |
 |
 |
 |
PROFILE |
 |
Eisai develops, manufactures, and distributes prescription and OTC pharmaceuticals, diagnostic products, and pharmaceutical production equipment around the world. Prescription drugs account for about 90% of sales and are led by Aricept, the firm's top seller that treats Alzheimer's disease. Other prescription drugs include Myonal, a muscle relaxant, and Aciphex, an acid reflux and ulcer treatment sold as Pariet in Japan and Europe. Eisai also makes food additives, livestock feeds, and veterinary drugs. The drugmaker has alliances with such pharmaceutical giants as Bayer (to market a diabetes drug) and Pfizer (Alzheimer's support program TriAD).
COMPETITION |
 |
DAIICHI PHARMACEUTICAL CO., LTD. (dossier)
Sankyo Co., Ltd. (4501)
Takeda Chemical Industries, Ltd. (4502)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: March
1999 Sales (mil.): 2,866.80
1-Yr. Sales Growth: 19.9%
Employees: 4,313
Revenue per employee: $664,688.15
KEY PEOPLE |
 |
Haruo Naito
CEO
Hideaki Matsui
CFO
CONTACT INFO |
 |
4-6-10 Koishikawa, Bunkyo-ku
Tokyo 112-8088, Japan
Phone: 81-3-3817-3700
Fax: 81-3-3811-3077
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |